Media coverage about Analogic Corporation (NASDAQ:ALOG) has trended somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Analogic Corporation earned a news sentiment score of 0.14 on Accern’s scale. Accern also gave headlines about the medical research company an impact score of 46.3232568359846 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
These are some of the headlines that may have impacted Accern’s scoring:
- Foetal Monitoring Devices Market Professional Survey Report 2017 (newsmaker.com.au)
- Analysis on Explosive Detectors Market – Global Industry Size, Share, Growth, Trends and Forecast 2016 – 2024 (mynewsdesk.com)
- Global Mammography Equipment Market Set for Rapid Growth and Trend, by 2021 (reports.pr-inside.com)
- Global Medical Image Analysis Software Market will Reach US$ 3,800 Mn By 2022 (medgadget.com)
- Analogic to showcase ConneCT scanner at Australian Airport Association’s National Conference (passengerterminaltoday.com)
Shares of Analogic Corporation (NASDAQ ALOG) traded down $0.35 during trading hours on Friday, hitting $80.00. 80,600 shares of the stock traded hands, compared to its average volume of 96,983. Analogic Corporation has a 52 week low of $66.00 and a 52 week high of $95.85. The firm has a market cap of $994.42, a P/E ratio of 47.83, a PEG ratio of 4.10 and a beta of 0.85.
The company also recently announced a quarterly dividend, which was paid on Friday, October 13th. Stockholders of record on Friday, September 29th were paid a $0.10 dividend. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.40 annualized dividend and a dividend yield of 0.50%. Analogic Corporation’s dividend payout ratio is presently -6.71%.
Several equities research analysts have recently commented on the stock. Jefferies Group LLC restated a “hold” rating and issued a $75.00 target price on shares of Analogic Corporation in a research note on Wednesday, September 20th. Zacks Investment Research upgraded shares of Analogic Corporation from a “hold” rating to a “buy” rating and set a $93.00 target price on the stock in a research note on Tuesday, October 10th. Three equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $85.25.
About Analogic Corporation
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corporation and related companies with MarketBeat.com's FREE daily email newsletter.